TWB-103 for Treating Lower Limb Ulcers on Patients With DM
Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
Primary Objective:
To assess the safety profile of TWB-103 administered to subjects with diabetic lower limb
ulcers
Secondary Objective:
To explore the efficacy of TWB-103 administered to subjects with diabetic lower limb ulcers